MedPath

A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease

Recruiting
Conditions
Major Cardiovascular Event
Established Atherosclerotic Cardiovascular Disease
Registration Number
NCT06295679
Lead Sponsor
Amgen
Brief Summary

The primary objective of the study is to evaluate real-world effectiveness of treatment with Repatha® in combination with SOC, compared with SOC alone, on the risk for cardiovascular (CV) death, myocardial infarction (MI), stroke, hospitalization for unstable angina, or coronary revascularization, whichever occurs first, in participants with established atherosclerotic CV disease (ASCVD) treated with SOC, according to local clinical practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
7000
Inclusion Criteria
  • Adult participants ≥ 18 years of age.
  • Participants or participant's legally authorized representative has provided informed consent to participate in this study.
  • Participants who meet one of the following:
  • Prescribed Repatha® in addition to an existing SOC treatment according to local guidelines and approved label.

OR

  • Already received SOC treatment prior to enrollment.
  • Participants with ANY of the following.
  • Diagnosis of MI OR stroke within 2 years before enrollment.
  • 2 MIs OR ≥ 2 strokes OR (≥ 1 MI AND ≥ 1 stroke) any time before enrollment.
  • Diagnosis of (MI OR stroke) AND diabetes.
  • Diagnosis of (MI OR stroke) AND documented multivessel disease (defined as > 50% stenosis of ≥ 2 major coronary arteries on coronary angiography or coronary artery contrast enhanced computed tomography).
  • Diagnosis of symptomatic peripheral arterial disease.
  • Most recent fasting LDL-C ≥ 70 mg/dL (≥ 1.8 mmol/L) or nonhigh-density lipoprotein cholesterol (non-HDL-C) ≥ 100 mg/dL (≥ 2.6 mmol/L) within 6 months prior to enrollment.
  • Most recent fasting triglycerides ≤ 400 mg/dL (≤ 4.5 mmol/L) within 6 months prior to enrollment.
Exclusion Criteria
  • Stroke within past 1 month.
  • Known hemorrhagic stroke at any time.
  • Stroke due to thromboembolic event.
  • Any prior use of Repatha® or other proprotein convertase subtilisin/kexin type 9 inhibition treatments within past 6 months prior to enrollment.
  • Participants currently enrolled in another study involving any investigational procedure, device or drug.
  • Participants prescribed Repatha® with a history of severe hypersensitivity or allergy to any subsidiary.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to CV Death, MI, Hospitalization for Unstable Angina, Stroke, or Coronary Revascularization, Whichever Occurs FirstUp to 72 months
Secondary Outcome Measures
NameTimeMethod
Time to CV Death, MI, or Stroke, Whichever Occurs FirstUp to 72 months
Percent Change in LDL-C From BaselineBaseline and end of follow-up (up to 72 months)
Change in Low-density Lipoprotein Cholesterol (LDL-C) From BaselineBaseline and end of follow-up (up to 72 months)
Number of Participants Who Experienced Adverse EventsUp to 72 months
Number of Participants Who Experienced Adverse Drug ReactionsUp to 72 months

Trial Locations

Locations (89)

The Third Peoples Hospital of Huizhou

🇨🇳

Huizhou, Guangdong, China

Zhuhai Peoples Hospital

🇨🇳

Zhuhai, Guangdong, China

China Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

Peking University First Hospital

🇨🇳

Beijing, Beijing, China

Fuwai Hospital Chinese Academy of Medical Sciences

🇨🇳

Beijing, Beijing, China

Beijing Friendship Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

Beijing Haidian Hospital

🇨🇳

Beijing, Beijing, China

Peking University Third Hospital

🇨🇳

Beijing, Beijing, China

Beijing Hospital

🇨🇳

Beijing, Beijing, China

Chongqing Emergency Medical Center

🇨🇳

Chongqing, Chongqing, China

Chongqing General Hospital

🇨🇳

Chongqing, Chongqing, China

Dongguan Songshan Lake Central Hospital

🇨🇳

Dong Guan, Guangdong, China

The First Peoples Hospital of Foshan

🇨🇳

Foshan, Guangdong, China

The First Affiliated Hospital Sun-Yat Sen University

🇨🇳

Guangzhou, Guangdong, China

The First Affiliated Hospital of Shantou University Medical College

🇨🇳

Guangzhou, Guangdong, China

Zhujiang Hospital of Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

Nanfang Hospital Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

The First Affiliated Hospital of Jinan University

🇨🇳

Guangzhou, Guangdong, China

The Third Affiliated Hospital of Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

The Sixth Affiliated Hospital Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

The First Peoples Hospital of Yulin

🇨🇳

Yulin, Guangxi, China

The Second Affiliated Hospital of Guilin Medical University

🇨🇳

Yulin, Guangxi, China

The Affiliated Hospital of Guizhou Medical University

🇨🇳

Guiyang, Guizhou, China

Cangzhou Central Hospital

🇨🇳

Cangzhou, Hebei, China

Tangshan Gongren Hospital

🇨🇳

Tangshan City, Hebei, China

Heilongjiang Provincial Hospital

🇨🇳

Haerbin, Heilongjiang, China

The Fourth Hospital of Harbin Medical University

🇨🇳

Harbin, Heilongjiang, China

Huaihe Hospital of Henan University

🇨🇳

Kaifeng, Henan, China

Nanyang Central Hospital

🇨🇳

Nanyang, Henan, China

The Seventh Peoples Hospital of Zhengzhou

🇨🇳

Zhengzhou, Henan, China

Fuwai Central China Cardiovascular Hospital

🇨🇳

Zhengzhou, Henan, China

The First Affiliated Hospital of Zhengzhou University

🇨🇳

Zhengzhou, Henan, China

The Central Hospital of Wuhan

🇨🇳

Wuhan, Hubei, China

Union Hospital Tongji Medical College Huazhong University of Science and Technology

🇨🇳

Wuhan, Hubei, China

Wuhan No 1 Hospital

🇨🇳

Wuhan, Hubei, China

Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology

🇨🇳

Wuhan, Hubei, China

Wuhan Third Hospital-Tongren Hospital of Wuhan University

🇨🇳

Wuhan, Hubei, China

Hunan Provincial Peoples Hospital

🇨🇳

Changsha, Hunan, China

Xiangya Hospital Central South University

🇨🇳

Changsha, Hunan, China

Changshu No1 Peoples Hospital

🇨🇳

Changshu, Jiangsu, China

Changshu No2 Peoples Hospital

🇨🇳

Changshu, Jiangsu, China

Nantong First Peoples Hospital

🇨🇳

Nantong, Jiangsu, China

The First Peoples Hospital of Kunshan

🇨🇳

Suzhou, Jiangsu, China

Wuxi Peoples Hospital

🇨🇳

Wuxi, Jiangsu, China

The Affiliated Hospital of Xuzhou Medical University

🇨🇳

Xuzhou, Jiangsu, China

Jiangxi Provincial Peoples Hospital

🇨🇳

Nanchang, Jiangxi, China

The First Affiliated Hospital of Nanchang University

🇨🇳

Nanchang, Jiangxi, China

The First Hospital of Nanchang

🇨🇳

Nanchang, Jiangxi, China

The Second Norman Bethune Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)

🇨🇳

Dalian, Liaoning, China

The First Affiliated Hospital of Dalian Medical University

🇨🇳

Dalian, Liaoning, China

The Second Hospital of Dalian Medical University

🇨🇳

Dalian, Liaoning, China

The First Affiliated Hospital of Jinzhou Medical University

🇨🇳

Jinzhou, Liaoning, China

General Hospital of Northern Theater Command

🇨🇳

Shenyang, Liaoning, China

The Fourth Affiliated Hospital of China Medical University

🇨🇳

Shenyang, Liaoning, China

Tangdu Hospital of Air Force Medical University

🇨🇳

Xi'an, Shaanxi, China

Shaanxi Provincial Peoples Hospital

🇨🇳

Xi'an, Shaanxi, China

Qilu Hospital of Shandong University

🇨🇳

Jinan, Shandong, China

Jinan Central Hospital

🇨🇳

Jinan, Shandong, China

The First Affiliated Hospital of Shandong First Medical University

🇨🇳

Jinan, Shandong, China

Provincial Hospital Affiliated to Shandong First Medical University

🇨🇳

Jinan, Shandong, China

Affiliated hospital of Jining Medical University

🇨🇳

Jining, Shandong, China

Zibo central Hospital

🇨🇳

Zibo, Shandong, China

Tongji Hospital of Tongji University

🇨🇳

Shanghai, Shanghai, China

Xinhua Hospital Affiliated To Shanghai Jiaotong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

First Hospital of Shanxi Medical University

🇨🇳

Taiyuan, Shanxi, China

The Second Hospital of Shanxi Medical University

🇨🇳

Taiyuan, Shanxi, China

The First Affiliated Hospital of Xi An Jiaotong University

🇨🇳

XI An, Shanxi, China

Sichuan Academy of Medical Sciences Sichuan Provincial Peoples Hospital

🇨🇳

Chengdu, Sichuan, China

Chengdu First Peoples Hospital

🇨🇳

Chengdu, Sichuan, China

Chengdu Third Peoples Hospital

🇨🇳

Chengdu, Sichuan, China

Tianjin Medical University General Hospital

🇨🇳

Tianjin, Tianjin, China

Tianjin Peoples Hospital

🇨🇳

Tianjin, Tianjin, China

Tianjin First Central Hospital

🇨🇳

Tianjin, Tianjin, China

Tianjin Chest Hospital

🇨🇳

Tianjin, Tianjin, China

Tianjin Huanhu Hospital

🇨🇳

Tianjin, Tianjin, China

The First Affiliated Hospital of Xinjiang Medical University

🇨🇳

Urumqi, Xinjiang, China

Yanan Hospital of Kunming City

🇨🇳

Kunming, Yunnan, China

First Affiliated Hospital of Kunming Medical University

🇨🇳

Kunming, Yunnan, China

The First Peoples Hospital of Yunnan Province

🇨🇳

Kunming, Yunnan, China

Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

the First Peoples Hospital of Xiaoshan District Hangzhou

🇨🇳

Hangzhou, Zhejiang, China

Huzhou Central Hospital

🇨🇳

Huzhou, Zhejiang, China

The First Peoples Hospital of Huzhou

🇨🇳

Huzhou, Zhejiang, China

Jiaxing Second Hospital

🇨🇳

Jiaxing, Zhejiang, China

The First Affiliated Hospital of Ningbo University

🇨🇳

Ningbo, Zhejiang, China

Ningbo Medical Center Lihuili Hospital

🇨🇳

Ningbo, Zhejiang, China

Shaoxing Second Hospital

🇨🇳

Shaoxing, Zhejiang, China

Beijing Anzhen Hospital, Capital Medical University

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath